Read on Twitter
Were you planning to be in Houston for #AMCPAnnual ? @amcporg @npcnow https://twitter.com/amcporg/status/1248246977583710208
While you’re safely socially distancing from home, take a few minutes to stop by my virtual poster [U45] on the @amcporg e-learning platform @Jennifersgraff @robertwdubois
Takeaway #1: A group of diverse stakeholders DISAGREED ON WHEN #steptherapy practices are appropriate.
Takeaway #2: However, these same stakeholders AGREED ON HOW #steptherapy should be developed, implemented, communicated and evaluated.
Takeaway #3: Most of these criteria were rated as standards we can achieve today - i.e. using up-to-date evidence, communicating information to patients and prescribers.
Takeaway #3 (cont.) Others were rated as best practices - i.e. e-tracking patient status on a protocol (like a delivery app for your prescription drugs), publicly reporting outcomes from #steptherapy
What did we do? (Part 1):
1. Identified common themes across guiding principles & legislation for ST/PA
2. Engaged a subgroup of experts in criteria checklist development
1. Identified common themes across guiding principles & legislation for ST/PA
2. Engaged a subgroup of experts in criteria checklist development
What did we do? (Part 2):
3. Convened a multistakeholder roundtable (patients, physicians, plans, pharmacists, policy & ethics)
4. Used a Modified Delphi Panel to assess consensus - standard vs. best practice?
3. Convened a multistakeholder roundtable (patients, physicians, plans, pharmacists, policy & ethics)
4. Used a Modified Delphi Panel to assess consensus - standard vs. best practice?
Do you agree with these standards and best practices?
